Brink's Affirms 2021 Guidance

Brink's Co. (BCO) said that it affirmed its 2021 guidance including revenue growth of 21% to about $4.45 billion at the midpoint, which is up 10% on an organic basis. Analysts polled by Thomson Reuters expect the company to report revenues of $4.41 billion for fiscal year 2021. Analysts' estimates typically exclude special items.

The company expects 2021 adjusted EBITDA growth of 25% to about $705 million.

In 2022, the company targets organic revenue growth of 5% to 7%, adjusted EBITDA growth in the mid-teens to a range between $785 million and $825 million, and free cash flow growth of more than 50% to a range between $350 million and $400 million.

The company noted that 2021 guidance, and its expected post-pandemic return to mid-single-digit organic revenue growth and double-digit profit growth, are driven primarily by core operations.

The company said its strategy 2.0 digital initiatives, with the exception of the PAI acquisition, are not included in current outlook for 2021 or 2022, though the company expects the initiatives to drive additional organic revenue and profit growth in 2022 and beyond.

The company plans to disclose additional financial targets for 2022 and 2023 at Investor Day event in November.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Federal Communications Commission or FCC has granted SpaceX Services, Inc. authorization to use its Starlink satellite internet system on vehicles in motion. SpaceX, owned by Elon Musk, is allowed to operate consumer and enterprise Ku-band Earth Stations in Motion or ESIM using frequencies allocated to the fixed satellite service. The approval would help the company to expand its services to Loud Muscle Science, LLC is recalling certain Launch Sequence products in the United States and Canada citing the presence of undeclared Tadalafil, the U.S. Food and Drug Administration said. These tainted Launch Sequence Capsule products are marketed as dietary supplements for male sexual enhancement. The U.S. Food and Drug Administration announced the intended availability of around 17 million bottles equivalent of general infant formula to be imported from New Zealand and Ireland. Under the FDA's enforcement discretion to source more infant formula to the U.S., French food company Danone SA will send 555,000 cans Aptamil Gold Plus from New Zealand.
Follow RTT